Patents by Inventor Kevin Hammond

Kevin Hammond has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11890294
    Abstract: The present invention provides a composition for topical administration of a polyhydroxy acid, such as lactobionate and especially zinc lactobionate, and low pH to an external body surface such as skin. The composition is designed to be highly effective in delivering low pH and zinc lactobionate across the layers of the skin to more effectively treat and prevent skin conditions involving a defective skin barrier such as eczema and severe dry skin.
    Type: Grant
    Filed: October 13, 2021
    Date of Patent: February 6, 2024
    Assignee: HYPHENS PHARMA PTE. LTD.
    Inventors: Kevin Hammond, Adrian Davis
  • Publication number: 20230328417
    Abstract: There is disclosed a method of and a system for generating a unique identifier for a subject. Biometric data related to the subject is received. Identification markers from the biometric data are extracted. The unique identifier is generated from the extracted identification markers by identifying a given domain specific feature which has a predetermined identity compared to other domain specific features. Feature values are generated based on the biometric data and stored in a user profile of the subject.
    Type: Application
    Filed: September 3, 2021
    Publication date: October 12, 2023
    Inventors: Nelson L. JUMBE, Michael MORIMOTO, Andreas SCHUH, Todd ROOKE, Krzysztof KRAWIEC, Kevin HAMMOND
  • Publication number: 20230270735
    Abstract: The present invention is directed to a topical formulation comprising 1) a dispersed phase comprising: 5 to 15% w/w (percentage weight/weight) nicotinamide; 10 to 60% w/w of a partition coefficient enhancer (Pc enhancer), having a structure of the general formula: CnH2n+2O2 where n represents an integer from 3 to 6 inclusive; and ?10% water and 2) a continuous phase, wherein the formulation has a pH above 4.0. The present invention is also directed to a pharmaceutical composition comprising the topical formulation according to the invention, a pharmaceutical composition according to the invention for use in therapy, and the use of the topical formulation as a cosmetic agent.
    Type: Application
    Filed: July 27, 2021
    Publication date: August 31, 2023
    Applicant: INCANTHERA (R&D) LTD
    Inventor: Kevin Hammond
  • Publication number: 20220103922
    Abstract: A sensing system comprising a hand-held sensing device with a vibracoustic sensor module (VSM). The VSM comprises a voice coil component comprising a coil holder supporting wire windings; a magnet component comprising a magnet supported by a frame, a magnet gap configured to receive at least a portion of the voice coil component in a spaced and moveable manner; a connector connecting the voice coil component to the magnet component, the connector being compliant and permitting relative movement of the voice coil component and the magnet component; a diaphragm configured to induce a movement of the voice coil component in the magnet gap responsive to incident acoustic waves; a housing for retaining the vibroacoustic sensor module having a handle end and a sensor end, the sensor end having an opening, the VSM positioned such that at least a portion of the diaphragm extends across the opening.
    Type: Application
    Filed: December 9, 2021
    Publication date: March 31, 2022
    Inventors: Nelson L. JUMBE, Andreas SCHUH, Peter REXELIUS, Michael MORIMOTO, Dimosthenis KATSIS, Nikola KNEZEVIC, Steve KRAWCZYK, Kevin HAMMOND, Krzysztof KRAWIEC, Gregory A. KIRKOS
  • Publication number: 20220031721
    Abstract: The present invention provides a composition for topical administration of a polyhydroxy acid, such as lactobionate and especially zinc lactobionate, and low pH to an external body surface such as skin. The composition is designed to be highly effective in delivering low pH and zinc lactobionate across the layers of the skin to more effectively treat and prevent skin conditions involving a defective skin barrier such as eczema and severe dry skin.
    Type: Application
    Filed: October 13, 2021
    Publication date: February 3, 2022
    Applicant: HYPHENS PHARMA PTE. LTD.
    Inventors: Kevin HAMMOND, Adrian DAVIS
  • Patent number: 11240579
    Abstract: A sensing system comprising a hand-held sensing device with a vibracoustic sensor module (VSM). The VSM comprises a voice coil component comprising a coil holder supporting wire windings; a magnet component comprising a magnet supported by a frame, a magnet gap configured to receive at least a portion of the voice coil component in a spaced and moveable manner; a connector connecting the voice coil component to the magnet component, the connector being compliant and permitting relative movement of the voice coil component and the magnet component; a diaphragm configured to induce a movement of the voice coil component in the magnet gap responsive to incident acoustic waves; a housing for retaining the vibroacoustic sensor module having a handle end and a sensor end, the sensor end having an opening, the VSM positioned such that at least a portion of the diaphragm extends across the opening.
    Type: Grant
    Filed: November 12, 2020
    Date of Patent: February 1, 2022
    Assignee: LEVEL 42 AI
    Inventors: Nelson L. Jumbe, Andreas Schuh, Peter Rexelius, Michael Morimoto, Dimosthenis Katsis, Nikola Knezevic, Steve Krawczyk, Kevin Hammond, Krzysztof Krawiec, Gregory A. Kirkos
  • Patent number: 11173172
    Abstract: The present invention provides a composition for topical administration of a polyhydroxy acid, such as lactobionate and especially zinc lactobionate, and low pH to an external body surface such as skin. The composition is designed to be highly effective in delivering low pH and zinc lactobionate across the layers of the skin to more effectively treat and prevent skin conditions involving a defective skin barrier such as eczema and severe dry skin.
    Type: Grant
    Filed: May 10, 2018
    Date of Patent: November 16, 2021
    Assignee: HYPHENS PHARMA PTE. LTD.
    Inventors: Kevin Hammond, Adrian Davis
  • Publication number: 20210345939
    Abstract: A sensing system comprising a a hand-held sensing device with a vibracoustic sensor module (VSM). The VSM comprises a voice coil component comprising a coil holder supporting wire windings; a magnet component comprising a magnet supported by a frame, a magnet gap configured to receive at least a portion of the voice coil component in a spaced and moveable manner; a connector connecting the voice coil component to the magnet component, the connector being compliant and permitting relative movement of the voice coil component and the magnet component; a diaphragm configured to induce a movement of the voice coil component in the magnet gap responsive to incident acoustic waves; a housing for retaining the vibroacoustic sensor module having a handle end and a sensor end, the sensor end having an opening, the VSM positioned such that at least a portion of the diaphragm extends across the opening.
    Type: Application
    Filed: November 12, 2020
    Publication date: November 11, 2021
    Inventors: Nelson L. JUMBE, Andreas SCHUH, Peter REXELIUS, Michael MORIMOTO, Dimosthenis KATSIS, Nikola KNEZEVIC, Steve KRAWCZYK, Kevin HAMMOND, Krzysztof KRAWIEC, Gregory A. KIRKOS
  • Publication number: 20200222438
    Abstract: The present invention provides a composition for topical administration of a polyhydroxy acid, such as lactobionate and especially zinc lactobionate, and low pH to an external body surface such as skin. The composition is designed to be highly effective in delivering low pH and zinc lactobionate across the layers of the skin to more effectively treat and prevent skin conditions involving a defective skin barrier such as eczema and severe dry skin.
    Type: Application
    Filed: May 10, 2015
    Publication date: July 16, 2020
    Applicant: HYPHENS PHARMA PTE. LTD.
    Inventors: Kevin HAMMOND, Adrian DAVIS
  • Patent number: 5071747
    Abstract: A porous polymeric support for biological cells is prepared having a total pore volume of at least 75% formed by a plurality of voids having an average diameter within a range of from 1 and 150 .mu.m interconnected by holes. The support is prepared by forming an emulsion containing monomers and/or prepolymers in a continuous phase and having an internal phase that forms the voids of the support, and polymerizing the monomers and/or prepolymers in the continuous phase. The emulsion may be a water-in-oil emulsion with the monomers and/or prepolymers in the oil. Biological cells are introduced into at least the voids of the support. Preferably, the voids have an average size 3 to 15 times the cell size and the holes have an average size 1 to 8 times the cell size. A compound may be produced by passing reactants into the voids via the interconnecting holes to contact the cells in the voids to cause the cells to produce the compound.
    Type: Grant
    Filed: December 22, 1988
    Date of Patent: December 10, 1991
    Assignee: Unilever Patent Holdings B.V.
    Inventors: David B. Hough, Kevin Hammond, Christine Morris, Rober C. Hammond
  • Patent number: 5021462
    Abstract: A porous polymeric material has cell sizes within the range 100 to 0.5 .mu.m and total pore volume with respect to the overall volume of the material in the range 75 to 98% and includes cross-linked polycondensation polymeric material. The material can be made from a high internal phase emulsion in which the cross-linked polycondensation polymer is formed in the continuous phase. The materials are preferably open interconnected cellular structures. They can be made of a wide range of polycondensation materials. The materials are thus highly porous and light weight and have a range of properties depending primarily on their constituent polycondensation materials.
    Type: Grant
    Filed: October 31, 1990
    Date of Patent: June 4, 1991
    Assignee: Unilever Patent Holdings B.V.
    Inventors: Alfred R. Elmes, Kevin Hammond, David C. Sherrington
  • Patent number: 5019373
    Abstract: The present invention relates to oral compositions such as dentifrices or mouthwashes.By inclusion therein of a shorter chain mono- and dialkylphosphate as surfactant, a mild product is obtained which also has improved anti-caries properties.Preferred are sodium mono- and di-octyl phosphates for use in these compositions.
    Type: Grant
    Filed: November 29, 1989
    Date of Patent: May 28, 1991
    Assignee: Chesebrough-Pond's USA Co., Division of Conopco, Inc.
    Inventors: Peter Carter, Kevin Hammond
  • Patent number: 4985468
    Abstract: A porous polymeric material has cell sizes within the range 100 to 0.5 .mu.m and total pore volume with respect to the overall volume of the material in the range 75 to 98% and includes cross-linked polycondensation polymeric material. The material can be made from a high internal phase emulsion in which the cross-linked polycondensation polymer is formed in the continuous phase. The materials are preferably open interconnected cellular structures. They can be made of a wide range of polycondensation materials. The materials are thus highly porous and light weight and have a range of properties depending primarily on their constituent polycondensation materials.
    Type: Grant
    Filed: April 25, 1988
    Date of Patent: January 15, 1991
    Assignee: Unilever Patent Holdings B.V.
    Inventors: Alfred R. Elmes, Kevin Hammond, David C. Sherrington